PMID: 2095385Dec 1, 1990Paper

Parathyroid hypertensive factor

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
P K PangC G Benishin

Abstract

A new circulating hypertensive factor, parathyroid hypertensive factor (PHF), has been demonstrated in the plasma of spontaneously hypertensive rats (SHR) but not in that of normotensive rats. PHF produced a delayed increase in blood pressure with a peak response after 45 min (bolus injection) or 60-90 min (continuous infusion). This increase in blood pressure was coupled with an in vitro increase in calcium uptake in the rat tail artery which had a similar time-course. The evidence that calcium is involved in the mechanism of action is supported by the inhibitory effect of calcium antagonists on the vascular action of PHF. Furthermore, PHF increased the intracellular free calcium concentration in cultured smooth muscle cells from the rat tail artery. Parathyroidectomy and parathyroid transplant experiments indicated that PHF originated in the parathyroid gland. Cultured parathyroid glands from SHR but not from normotensive rats produced a factor in the medium with the same biological property and retention time on high performance liquid chromatography as plasma PHF. A novel cell type was described in the parathyroid gland of SHR, but not normotensive rats, and the percentage of these cells was correlated significantly with th...Continue Reading

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Experimental Gerontology
P K PangR Z Lewanczuk
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
R Z LewanczukP K Pang
© 2021 Meta ULC. All rights reserved